Navigation Links
ADMIRE-HF Clinical Trial Published in the Journal of the American College of Cardiology
Date:5/17/2010

ts at the highest risk for cardiac events and cardiac death. The two-year cardiac event rate for patients with BNP above the median of 140 ng/l was 42%, but among patients with H/M greater than or equal to 1.60, the rate was 20.5%. Whereas there were no cardiac deaths among the 57 patients with BNP >140 ng/l and H/M greater than or equal to 1.60, there were 42 cardiac deaths among the 406 patients (10.3%) with above-median BNP and H/M <1.60.(1)

The subanalyses also demonstrated a modest but statistically significant positive correlation between LVEF and H/M. The two-year cardiac event rate for individuals with LVEF <30% and H/M greater than or equal to 1.60 was less than half that of all patients with LVEF <30% (17.6% vs. 40.3%, respectively). There were two cardiac deaths among the 81 patients (2.5%) with LVEF <30% and H/M greater than or equal to 1.60, as compared with 39 cardiac deaths among the 409 (9.5%) patients with LVEF <30% and H/M <1.60. There were no cardiac deaths among the 120 patients with LVEF greater than or equal to 30% and H/M greater than or equal to 1.60.(1)

About Heart Failure

According to the American Heart Association, 5.7 million Americans suffer from heart failure. Cardiovascular disease in all its forms claims about as many lives each year as cancer, chronic lower respiratory diseases, accidents, and diabetes combined.  Patients who have previously suffered from heart failure have a sudden death rate that is six to nine times greater than the general population.(1)

About AdreView

AdreView™ (Iobenguane I 123 Injection) is a molecular imaging agent.  GE Healthcare began developing AdreView in 2004, and the agent was granted orphan-drug status by the Food and Drug Administration (FDA) in December 2006. In <
'/>"/>

SOURCE GE Healthcare
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
2. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
3. 3M and CitiusTech to Integrate 3M Healthcare Data Dictionary With CitiusTechs BI-Clinical Healthcare Business Intelligence Framework
4. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
5. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
6. Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes
7. Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
8. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
9. US HIFU Receives Unanimous Approval to Continue the Clinical Investigation of High Intensity Focused Ultrasound (HIFU) for Treatment of Prostate Cancer
10. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
11. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Eli Lilly and Company (NYSE: ... scams, purportedly using the name of the company and/or ... the public through postal mail solicitations and job-seekers through ... any foreign lottery organizations and do not conduct the ... of the scam. The activities described in these scams ...
(Date:6/19/2013)... , June 19, 2013   NextDocs announced ... service clinical research organization, at DIA 2013 , ... companies will present case studies that explore best practices ... to electronic trial master file (eTMF) systems. ... will present alongside Krystyna Kowalczyk , executive vice ...
(Date:6/19/2013)... , June 19, 2013   BioCision ... sample standardization and handling in many areas of ... of new patents by the U.S. Patent Office ... products developed to standardize sample handling to ensure ... results in common laboratory procedures. ...
Breaking Medicine Technology:Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests 2NextDocs and Novella to Present on eTMF at DIA 2013 2BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... 2012 Mylan Inc. (Nasdaq: MYL ) ... received final approval from the U.S. Food and Drug ... for Fluvastatin Capsules USP, 20 mg and 40 mg, ... Capsules. This product is indicated for the treatment of ...
... Maine, April 12, 2012 Expanding on the ... devices, Puritan Medical Products Co. LLC launches two ... use through its newly created division, Puritan Diagnostics ... Our universal transport media system has ...
Cached Medicine Technology:Mylan Launches First Generic Version of Lescol® Capsules 2Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems 2
(Date:6/19/2013)... international study led by researchers at The University of ... continues to show remarkable promise for the treatment of ... most recent interim findings of the 18-center Phase 2 ... Journal of Medicine . Previous interim findings were presented ... Hematology Annual Meeting and Exposition. , Unprecedented ...
(Date:6/19/2013)... Children had half as many emergency department visits ... on five or more days a week, according to ... Children,s Hospital and Johns Hopkins University. , The new ... Journal of Pediatrics and will be presented at ... an important step in understanding where primary care practices ...
(Date:6/19/2013)... -- Nearly 70 percent of Americans are ... than half take two, Mayo Clinic researchers say. ... prescribed, their study found. Twenty percent of patients ... to the findings, published online in the journal ... For audio and video of Dr. Jennifer St. ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 North ... announced organizational changes to advance development of its ... said, “To support the advanced development of our ... changes to the Company’s management structure and engaged ... The Company announced that Michael Galiger will serve ...
(Date:6/19/2013)... Atlanta, Ga (PRWEB) June 19, 2013 ... billing and business management software solutions for the post-acute care ... position 79 - on the Healthcare Informatics 100 (HCI ... healthcare IT companies in the U.S. in terms of revenue ... grown at an average rate of 85% annually, and the ...
Breaking Medicine News(10 mins):Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3
... million commitment from James H. and Marilyn H. Simons ... as part of Memorial Sloan-Ketterings new Brain Tumor Center ... to achieve fundamental new insights into the molecular and ... plan to apply that knowledge to the creation of ...
... of Lifetime,s Nonpartisan Every Woman Counts Election Year, ... Issues That Matter Most -, NEW YORK, Feb. ... Heart Month, Lifetime Television launches its third annual Don,t,Skip ... the nation,s leading women,s health experts, the Network offers,a ...
... - The field of presidential contenders dwindled Wednesday when ... John Edwards (D-N.C.) dropped out of the race. ... frontrunners will continue to face a formidable challenge from ... season will intensify this weekend as the candidates visit ...
... Feb. 1 While winter,s harsh, windy weather,is often ... of lip,irritation is harder to pinpoint. In fact, several ... have been linked to dry lips. The,key is determining ... to eliminate the problem., Speaking today at the ...
... International Associates, Inc,administrator for the HealthShares(TM) Indexes, a ... Funds, today announced,that effective at the opening of ... ALOG ) will replace Ventana Medical Systems,Inc. ... Index. Ventana,s is,being acquired by Roche group based ...
... ALLEGAN, Mich., Feb. 1 The Perrigo Company,(Nasdaq: ... Board of Directors has,authorized the repurchase of $150 ... 2010 under its ongoing share repurchase program. Any,remaining ... on,February 8, 2009. Under share repurchase programs since ...
Cached Medicine News:Health News:Simons Foundation grant boosts brain tumor research 2Health News:Lifetime Television Launches Third Annual Don't Skip a Beat Multi-Platform Heart Health Awareness Initiative 2Health News:Lifetime Television Launches Third Annual Don't Skip a Beat Multi-Platform Heart Health Awareness Initiative 3Health News:Election 2008: Sleep deprivation a tough opponent for presidential candidates 2Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 2Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 3Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 4
Inquire...
Hush Puppies Pups feature vibrant colors and playful styling for children. Kids love the added comfort while parents love the durable designs found in every Hush Puppies Pups frame....
... Recognized for classic styling, Tura's original collection ... with discriminating taste. Tura designs exemplify the ... and style with quality and durability. The ... set the Tura woman apart. Rich colors ...
... The collection features a variety of ... array of feminine styles designed with ... both men and women that are ... materials as used in our fine ...
Medicine Products: